导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 12.90% | 278/1050 |
| 近一周 | -4.00% | 1033/1104 |
| 近一月 | -1.94% | 347/1103 |
| 近一季 | 1.16% | 243/1092 |
| 近半年 | 2.99% | 371/1070 |
| 近一年 | 22.04% | 229/1018 |
| 近两年 | 52.07% | 503/926 |
| 近三年 | 42.88% | 317/834 |
| 成立以来 | 214.40% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
4.53% 166/1070 |
3.90% 630/1101 |
- - |
- - |
| 2025 | 18.11% 697/1065 |
-2.80% 943/1014 |
-2.54% 867/1038 |
18.17% 658/1050 |
5.52% 118/1065 |
| 2024 | 13.13% 215/1011 |
-1.02% 367/960 |
3.62% 137/983 |
13.53% 343/991 |
-2.84% 520/1011 |
| 2023 | -12.87% 432/952 |
-2.52% 735/880 |
-1.33% 253/895 |
-6.50% 389/915 |
-3.11% 335/952 |
| 2022 | -16.30% 205/867 |
-20.01% 516/773 |
10.40% 247/806 |
-6.08% 82/845 |
0.90% 389/867 |
| 2021 | 24.64% 117/740 |
-5.84% 378/580 |
11.15% 326/659 |
6.92% 92/704 |
11.39% 47/740 |
| 2020 | 62.11% 183/554 |
-6.18% 321/419 |
26.55% 171/466 |
24.39% 20/517 |
9.76% 366/554 |
| 2019 | 34.29% 262/410 |
20.55% 904/1146 |
4.66% 49/1228 |
2.19% 273/390 |
4.15% 359/410 |
| 2018 | -20.16% 83/349 |
- - |
-4.98% 186/990 |
-2.31% 325/1000 |
-14.43% 852/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 汇添富高端制造股票A VS. 东吴新产业精选股票A(580008) |